Clinical trials
Completed Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
366 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 6 |
| 2003 | 17 |
| 2004 | 7 |
| 2005 | 12 |
| 2006 | 18 |
| 2007 | 13 |
| 2008 | 12 |
| 2009 | 23 |
| 2010 | 23 |
| 2011 | 21 |
| 2012 | 18 |
| 2013 | 24 |
| 2014 | 15 |
| 2015 | 26 |
| 2016 | 13 |
| 2017 | 23 |
| 2018 | 14 |
| 2019 | 11 |
| 2020 | 15 |
| 2021 | 18 |
| 2022 | 8 |
| 2023 | 11 |
| 2024 | 7 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 366 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 61 |
| Merck KGaA, Darmstadt, Germany | 22 |
| Novartis Pharmaceuticals | 19 |
| Bayer | 15 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 8 |
| GlaxoSmithKline | 7 |
| Johns Hopkins University | 7 |
| EMD Serono | 6 |
| Genzyme, a Sanofi Company | 6 |
| Tanabe Pharma Corporation | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 366 |
| Multiple Sclerosis | 179 |
| Multiple Sclerosis, Chronic Progressive | 35 |
| Fatigue | 20 |
| Demyelinating Diseases | 10 |
| Autoimmune Diseases | 7 |
| Nervous System Diseases | 7 |
| Recurrence | 7 |
| Cognitive Dysfunction | 6 |
| Immune System Diseases | 4 |
Trials
Showing 26 to 50 of 366. Each trial links to its page on Pharma Observatory.
266 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.